BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Doxorubicin
,
rs3825942
,
IGF1
,
Angiogenesis
,
Lung cancer
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Interleukin- 3
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Interleukin 3 Inhibits Glutamate-Cytotoxicity in Neuroblastoma Cell Line.
Conformational and binding mode assessment of the human IL-3 recognition by its alpha receptor.
Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis.
Interleukin-3 protects against viral pneumonia in sepsis by enhancing plasmacytoid dendritic cell re…
MARCH3 negatively regulates IL-3-triggered inflammatory response by mediating K48-linked polyubiquit…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.
Analyses of Interleukin-6, Presepsin and Pentraxin-3 in the Diagnosis and Severity of Late-onset Pre…
A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 …
Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Mac…
Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ